Location History:
- Dallas, TX (US) (2014 - 2017)
- Coleraine, IE (2018)
Company Filing History:
5 out of 117 
1 out of 3,696 
Years Active: 2014-2018
Title: Innovations and Contributions of Sukanta Kamila
Introduction
Sukanta Kamila is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of pharmaceuticals through his innovative research and development of various compounds. With a total of 5 patents, his work focuses on creating effective inhibitors for various medical applications.
Latest Patents
Among his latest patents, Sukanta has developed compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as RAF kinase and LRRK2 inhibitors. This invention provides oxazine compounds, methods of using them, and methods of making these compounds for pharmaceutical use. Additionally, he has worked on quinoxaline compounds and derivatives, which also include methods of use and production for pharmaceutical applications.
Career Highlights
Sukanta Kamila has had a distinguished career, working with prestigious institutions such as Southern Methodist University and The Johns Hopkins University. His research has contributed to advancements in the pharmaceutical industry, particularly in the development of new therapeutic agents.
Collaborations
Sukanta has collaborated with notable colleagues, including Edward R. Biehl and Haribabu Ankati. These partnerships have further enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Sukanta Kamila's innovative work in the field of pharmaceuticals demonstrates his commitment to advancing medical science. His patents and collaborations reflect his significant contributions to the industry, making him a prominent figure in the realm of invention.